Scpharmaceuticals (NASDAQ:SCPH) announced its quarterly earnings results on Tuesday. The company reported ($0.80) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.53) by ($0.27), Bloomberg Earnings reports.

Shares of Scpharmaceuticals stock traded up $0.48 during midday trading on Thursday, hitting $12.96. The stock had a trading volume of 83,297 shares, compared to its average volume of 49,273. Scpharmaceuticals has a 52 week low of $11.50 and a 52 week high of $18.17.

How to Become a New Pot Stock Millionaire

Several brokerages have commented on SCPH. Leerink Swann began coverage on Scpharmaceuticals in a research note on Tuesday, December 12th. They set an “outperform” rating and a $20.00 price target for the company. BMO Capital Markets began coverage on Scpharmaceuticals in a research note on Tuesday, December 12th. They set an “outperform” rating and a $24.00 price target for the company. Jefferies Group assumed coverage on Scpharmaceuticals in a research note on Tuesday, December 12th. They set a “buy” rating and a $23.00 price target for the company. Finally, Zacks Investment Research downgraded Scpharmaceuticals from a “hold” rating to a “sell” rating in a research report on Wednesday, February 14th.

ILLEGAL ACTIVITY NOTICE: “Scpharmaceuticals (SCPH) Issues Quarterly Earnings Results” was originally published by Watch List News and is the sole property of of Watch List News. If you are viewing this report on another site, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The legal version of this report can be accessed at https://www.watchlistnews.com/scpharmaceuticals-scph-issues-quarterly-earnings-results/1958347.html.

Scpharmaceuticals Company Profile

scPharmaceuticals, Inc, is a biopharmaceutical company. The Company is engaged in developing pharmaceutical products for subcutaneous delivery. The Company offers sc2Wear Infusor, which is a small pump that attaches to the body using a standard medical adhesive. The sc2Wear Infusor injects the drug into the body slowly, similar to an intravenous (IV) drip.

Receive News & Ratings for Scpharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scpharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.